Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Notable ETF Inflow Detected - XBI, EXEL, FMI, HALO
Wednesday, March 11, 10:56 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, EXEL, FMI, HALO Exchange traded funds (ETFs) trade just ...

HALO: Insiders vs. Shorts
Tuesday, March 17, 3:19 PM ET, by Market News Video Staff

The most recent short interest data was recently released by the NASDAQ for the 02/27/2015 ...

Notable ETF Outflow Detected - XBI, FMI, HALO, EXEL
Tuesday, March 24, 11:28 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, FMI, HALO, EXEL Exchange traded funds (ETFs) trade just ...

Commit To Purchase Infinity Pharmaceuticals At $10, Earn 7.4% Annualized Using Options
Wednesday, March 25, 11:33 AM ET, by Market News Video Staff

Investors eyeing a purchase of Infinity Pharmaceuticals Inc (INFI) stock, but tentative about paying the ...

Commit To Buy Halozyme Therapeutics At $10, Earn 15.5% Using Options
Tuesday, March 31, 11:30 AM ET, by Market News Video Staff

Investors eyeing a purchase of Halozyme Therapeutics Inc (HALO) stock, but tentative about paying the ...

  More articles:  1 2 3 4 5 6 7 next »

INFI Crosses Below Key Moving Average Level

By Market News Video Staff, Tuesday, August 23, 11:56 AM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Tuesday, shares of Infinity Pharmaceuticals Inc (INFI) crossed below their 200 day moving average of $6.60, changing hands as low as $6.50 per share. Infinity Pharmaceuticals Inc shares are currently trading up about 1.3% on the day. The chart below shows the one year performance of INFI shares, versus its 200 day moving average:

Infinity Pharmaceuticals Inc 200 Day Moving Average Chart

Looking at the chart above, INFI's low point in its 52 week range is $4.42 per share, with $10.42 as the 52 week high point that compares with a last trade of $6.99.

INFI operates in the Biotechnology sector, among companies like NPS Pharmaceuticals Inc. (NPSP) which is up about 1.8% today, and Halozyme Therapeutics Inc (HALO) trading up by about 1.4%. Below is a three month price history chart comparing the stock performance of INFI, versus NPSP and HALO.

INFI,NPSP,HALO Relative Performance Chart


The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   Below   Crossing   Growth   HALO   Halozyme   INFI   Infinity   Looking   NPSP   Pharmaceuticals   Start   Stocks   Their   Therapeutics   Trial   about   allows   asset   average   below   changing   chart   commodities   compares   currently   designed   flexibility   follow   history   level   month   moving   performance   point   portfolio   program   range   raquo   regions   sector   sectors   share   shares   that   trading   versus   week   wherever   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

INFI Crosses Below Key Moving Average Level | Market News Video | Copyright © 2008 - 2015, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.